Study Shows Once-Yearly Reclast Better Than Risedronate At Increasing Bone Mass In Patients With Osteoporosis Caused … (Medical News Today)
New data show that a once-yearly infusion of Reclast® (zoledronic acid) Injection 5mg was significantly better than risedronate at increasing bone mass in patients with osteoporosis caused by glucocorticoids, commonly known as steroids3. These medications are widely used to treat inflammatory conditions but can cause bone loss and osteoporosis1.